NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) — The global solubility enhancement excipient market is expected to witness a CAGR of 9.9%, and is projected to reach USD 1,775.5 million by 2024. This growth is attributed to the introduction of super generics. Moreover, the increasing demand of biopharmaceuticals is anticipated to fuel the demand.
Solubility is one of the important parameters to achieve preferred concentration of drug in systemic circulation for achieving required pharmacological response. Hydrophobic drugs frequently require high doses and need high dosage regimens to influence therapeutic plasma concentrations after administration. Low aqueous solubility is the main problem encountered with preparation and development of New Chemical Entities (NCEs) as well as for generic drugs. In order to overcome the low aqueous solubility, solubility enhancement excipients plays a crucial role in achieving the desired concentration in complete circulation for pharmacological response.
OSDF drives the market exhibiting the highest growth rate over the forecast period
The growing usage of solubility excipient is primary attributed to properties enhancing the bioavailability of poorly water soluble drugs in OSDF. Excipients contributes in achieving the improvement of the bioavailability by means conventional formulation technologies and method. Usage of solubility excipient helps in reducing developmental costs and provide opportunities to differentiate products through new modes of drug delivery, providing boost to the market growth. Further, new types of excipients and innovative formulation extend their application in OSDF contributing overall to the market growth.
The report segments solubility enhancement excipient market on the basis of type, technology, application and region. To view a summary of this report, go to the link provided below: https://www.energiasmarketresearch.com/global-solubility-enhancement-excipient-market-report/
Solubility enhancement excipient Market – Regional insight
Europe is accounted to hold the maximum share of the global market. Development of new treatments for chronic diseases, more spending on research and development and growing bioequivalence market all contribute to the market growth in the region. The market in Asia-Pacific is expected to follow an upward trend registering highest CAGR over the forecast period. Increasing expenditure in healthcare sector and presence of large pharmaceuticals companies with growing business couples with economies of scale propels the market growth in the APAC region. North America home to major players operating in excipient market are in continuous phase of developing generic drugs and solubility enhancer represent key region in the global solubility enhancement excipient market.
Key findings from the report:
- The global solubility enhancement excipient market is likely to reach USD 1,775.5 million by 2024
- The lipid excipient segment holds the major share of the market in 2017, and the trend is expected to continue over the forecast period
- The OSDF application segment held the major market in 2017 and is likely to exhibit the fastest CAGR from 2018 to 2024
- Europe held the largest share of the industry while, Asia-Pacific is expected to register highest CAGR over the forecast period
- Some of the key companies operating in the market include BASF SE, Abitec, Ashland Inc., Croda International Plc, DowDuPont, Evonik Industries, Gattefossé SAS, Shin-Etsu Chemical Co., Ltd., Clariant, Maple Biotech, among others.
- Lipid Excipients
- Polymer Excipients
- Surfactant Excipients
- Solid Dispersion Technology
- Particle Size Reduction Technology
- Micellar Solubilization Technology
- Lipid Solubilization Technology
- Complexation Technology
- Solid dosage form
- Parental dosage
- North America
- Rest of the World (ROW)
About Energias Market Research –
Energias Market Research Pvt. Ltd. publishes high quality reports, in-depth market research studies, to help clients obtain investment level clarity on current business scenario, trends and segmentation for their future developments. We are committed to our client’s needs, by providing high quality custom reports solutions best fit for strategy development and implementation to high return of invest (RoI). We believe that exceptional problems need expertise to solve, and with the help of our industries expertise we are able to offer an in depth understanding of what’s crucial, what’s applicable, and what it takes to ensure accomplishment in any business or venture.
Mr. Manas Nagi
Business Development Manager
For any queries email us: email@example.com
To purchase report: firstname.lastname@example.org
Call us: +1-716-239-4915